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granular cell layer of the olfactory bulb; NSC, neural stem cell; PBS, phosphate buffer saline; 
PFA, paraformaldehyde; RMS, rostral migratory stream; RT, room temperature; SVZ, 
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Journal category: Cancer Cell Biology. 
This study reports the subsequent isolation of human glioblatoma cells able to initiate 
experimental brain tumors, specifically and repeatedly found in the subventricular zones and 
olfactory bulbs following xenograft in the caudate putamen of immunodeficient mice.
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In patients with glioblastoma multiforme, recurrence is the rule despite continuous 
advances in surgery, radiotherapy and chemotherapy. Within these malignant gliomas, 
glioblastoma stem cells or initiating cells have been recently described and they were 
shown to be specifically involved in experimental tumorigenesis.  In this study, we show 
that some human glioblastoma cells injected into the striatum of immunodeficient nude 
mice exhibit a tropism for the subventricular zones.  There and similarily to neurogenic 
stem cells, these subventricular glioblastoma cells were then able to migrate towards the 
olfactory bulbs.  Finally, the glioblastoma cells isolated from the adult mouse 
subventricular zones and olfactory bulbs display high tumorigenicity when secondary 
injected in a new mouse brain.  Together, these data suggest that neurogenic zones could 
be a reservoir for particular cancer-initiating cells. 
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Introduction 
Malignant gliomas are the commonest primary brain tumors in adult and their most aggressive 
form, glioblastoma multiform (GBM, WHO grade IV), is also the most prevalent subtype.1 
Despite aggressive treatments combining surgery, chemotherapy and radiotherapy, the median 
survival hardly reaches 12 to 15 months and virtually all tumors relapse within 5 years from 
diagnostic.2, 3 A better understanding of the mechanisms leading to tumor recurrence is thus 
mandatory.   
 Several years ago, the discovery of a highly tumorigenic cell population, cancer stem 
cells4 or cancer-initiating cells5 in malignant gliomas shed some light on the mechanisms of 
tumor recurrence. Although their origin remains debated, these cancer-initiating cells exhibit 
self-renewal capacities and express multiple neural stem cell (NSC) markers.6 They may find 
shelter in perivascular niches and escape conventional treatments7, 8 and can, when 
xenografted in animal models, initiate the formation of complete glial tumors. The existence 
of such niches could help explain why gliomas recur within a short distance from the initial 
tumor margins. Distant recurrences however also exist, and are increasingly seen as patient 
survival is prolonged with the use of new treatment regimen. The recurrent tumor then 
frequently grows in the vicinity of ventricles, even if the tumor did not initially grow close to 
this structure.9, 10 Two explanations to this phenomenon may be suggested. First, adult NSC 
could be involved in the pathogenesis of brain tumors, with glioblastoma-initiating cells 
(GIC) emerging from genetic mutations in adult NSC leading to cancer.11-15 After treatment, 
some GIC might subsist and spread in the neurogenic zones, and could give rise to new 
tumors. Since the discovery of the persistence of neurogenesis in the adult mammalian16, 17 
and human brain,18 different studies have demonstrated that the subventricular zone (SVZ) of 
the forebrain is the largest neurogenic niche while dentate gyrus in the hippocampus is a more 
restrictive zone, with a lower neuronal production.19, 20 The precise physiological environment 
present in the SVZ, consisting of specialized cell organization and vascularization, supports 
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the NSC maintenance and their asymmetric division.21 The second, non exclusive 
explanation, is that GIC, which show characteristics that are similar to those of NSC, could 
present a tropism for the neurogenic zones and migrate towards the subventricular area where 
they would physically escape surgery and radiation therapy, become quiescent and thus, resist 
to chemotherapy, and later resume growth. 
In this paper, using orthotopic xenografts of human malignant glioma cell line and 
primary GBM cultures in adult immunodeficient mice, we showed that some tumor cells 
migrate specifically towards neurogenic zones (i.e. the SVZ). In the SVZ, these cells then 
express markers of NSC and mimic their behavior by migrating to olfactory bulbs (OB). 
When isolated and re-injected in other animals, these distant tumor cells are highly 
tumorigenic. Together, these results suggest that the migration of GIC into the adult 
neurogenic regions may hypothetically contribute to the relapse of GBM and maybe to the 
late periventricular pattern of recurrence observed in GBM. 
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Materials and methods 
Animals 
We used adult P40 female immunodeficient athymic nude mice, Crl:NU-Foxn1nu, obtained 
from Charles River® animal facilities (Charles River Laboratories®, Wilmington, UK).  All 
animals were taken care of in accordance with the declaration of Helsinki and following the 
guidelines of the Belgium ministry of agriculture in agreement with EC laboratory animal 
care and use regulation (86/609/CEE, CE of J n°L358, 18 December 1986).  The athymic 
nude mice were housed in sterilised filter-topped cages. 
 
Cell cultures 
One primary GIC primary culture (GB138) was established from acutely resected human 
GBM originated from a woman and validated as previously described.22, 23  Briefly, tumor 
tissue was washed twice in phosphate buffer saline (PBS, Gibco®), minced and placed in T75 
flask (Corning®, Corning, NY, USA) in DMEM containing 10% of foetal bovine serum (FBS,  
Invitrogen®, Merelbeek, Belgium).  After 2-3 weeks, cells were collected and resuspended at 
the density of 25.000 cells/mL in serum-free defined medium consisting of DMEM/F12 
containing B27 (Invitrogen®) and supplemented daily with recombinant human epidermal 
growth factor and recombinant human fibroblast growth factor 2 (EGF, 20ng/mL and FGF-2, 
10ng/mL respectively, Preprotech®, Rocky Hill, NJ, USA).  Under these culture conditions, 
cells were maintained as floating spheres.  When spheres became visible under microscope, 
we tested their ability to self-renew using secondary spheres culture assays.  Briefly, spheres 
were incubated 15 min at 37°C in papaïn (Wothington®, Lakewood, NJ, USA), the reaction 
was stopped with ovomucoïde (Wothington®) and then, cells were mechanically dissociated.  
Finally, the cell suspension was cultured as the primary culture sphere assays. 
Glioma cell line U87MG was obtained from the American Type Culture Collection (ATCC) 
and cultivated in serum-containing medium.  U87MG/DsRed cells expressing red fluorescent 
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protein were also used. To stimulate the formation of floating spheres, cells were cultivated in 
B27-supplemented DMEM/F12 medium as described above. Cultures were maintained at 
37°C under a humidified atmosphere containing 5% carbon dioxide. 
 
Intracranial transplantation of tumor cells into nude mice 
Mice were anaesthetized with an intra-peritoneal injection of a Rompun® (Sedativum 2%, 
Bayer®, Bruxelles, Belgium) and Ketalar® (Ketamin 50mg/mL, Pfizer®, Bruxelles, Belgium) 
solution (V/V) prepared just before injection.  A suspension of 50.000 or 100 GBM cells in 
2µL of PBS solution was injected into the right striatum of the athymic nude mice. The mouse 
head was maintained within a stereotactic frame, allowing a precise and reproducible injection 
site, using the intersection of the coronal and sagittal sutures (bregma) as reference.  The 
coordinates used were 0.5mm anterior and 2.5mm lateral from the bregma and at a depth of 
3mm.  This injection site is 1.2mm distant from the SVZ.  Mice were sacrificed at 24H, 1, 2, 3 
or 4 weeks after injection for U87MG cells and after 4, 6, 8, 10 weeks for GB138 GIC.  For 
secondary injections, the olfactory bulb (OB), the SVZ and the tumour mass (TM) were 
isolated from 400µm thickness sections obtained with a Leica vibratome (Leica VT1000S, 
Groot Bijgaarden, Belgium). Thereafter, tissues were incubated in papaïn (Wothington®, 
Lakewood, NJ, USA) for 30 min at 37°C and ovomucoïde (Wothington®) was added to stop 
the dissociation. Then, U87MG cells were plated in 6-well dishes in DMEM containing 10% 
of FBS and GB138 cells in serum-free defined medium at the density of 25.000 cells/mL.  
Human cells were selected with one passage allowing the selection of more than 99% of 
human cells.  GBM cells were then passed and grafted as described above in a secondary 
mouse brain or cultured as floating spheres in specific medium.  
 
Processing of tissue sections and cell cultures for immunolabelling 
Mice were anaesthetised with a Nembutal® injection (Pentobarbital 60mg/mL, Ceva Sante 
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Animal®, Bruxelles, Belgium) before an intracardiac perfusion with a NaCl 0,9% solution 
(VWR International®, Prolabo, USA), followed by paraformaldehyde (P.F.A.) 4% at 4°C 
(4,3g/L NaOH, 40g/L paraformaldehyde, 18,8g/L NaH2PO4).  Brains were removed and 
postfixed in P.F.A. 4% for 2H, then cryoprotected for 48H in PBS containing 20% sucrose 
before being frozen at -20°C in a 2-methylbutane solution (Sigma®, Bornem, Belgium).  
Fourteen micrometer thick coronal and sagittal sections were cut on a cryostat and stored at -
20°C. 
 For immunocytofluorescence, cells were plated on coverslips coated with polyornithine 
for 1H at room temperature (0,1mg/mL, Sigma®). After a short washing in PBS, cells were 
fixed by incubation for 15 min at room temperature (RT) in P.F.A. 4% solution, then washed 
three times for 5 min in PBS. 
 
Immunolabelling and histology 
Permeabilization and blocking of unspecific binding sites were obtained by a 30 min 
incubation at RT in the blocking solution (5% donkey serum and 0,3% Triton X-100 in PBS).  
Primary antibodies were diluted in a carrier solution containing 0,2% donkey serum and 0,1% 
Triton X-100 in PBS.  We used antibodies directed against Nestin (chicken polyclonal IgG, 
1:250, Novus Biologicals®, Littleton, CO, USA), GFAP (mouse monoclonal IgG, 1:500, 
Sigma®, Bornem, Belgium), Human Mitochondria (mouse monoclonal IgG1, 1:250, 
Millipore®, Brussels, Belgium), Human Nuclei (mouse monoclonal IgG1, 1:250, Millipore®), 
Sox2 (rabbit polyclonal IgG, 1:250, Abcam®, Cambridge, UK and goat polyclonal IgG, 1:200, 
Santa-Cruz®), Ki67 (rabbit polyclonal IgG, 1:200, Abcam®), CD133 (rabbit polyclonal IgG, 
1:250, Abcam®), CD31 (rabbit polyclonal IgG, 1:500, Abcam®), Doublecortin (goat 
polyclonal IgG, 1:250, Santa-Cruz®), β-III-tubulin (rabbit polyclonal IgG, 1:1000, Covance®, 
Belgium), NeuN (rabbit polyclonal IgG, 1:500, Chemicon®) and GABA (guinea pig 
polyclonal IgG, 1:750, Chemicon®).  Brain sections or fixed cells were incubated with 
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primary antibodies at RT for 2H or at 4°C for the night.  Three 15 min washes were 
performed in PBS at RT.  We used biotinylated (Vector®, Brussels, Belgium) or RRX-, FITC- 
and Cy5-conjugated (Jackson Immunoresearch Laboratories®, West Grove, PA, USA) 
secondary antibodies.  All secondary antibodies were diluted at 1:500 in the carrier solution.  
Finally, tissue sections were washed three times with PBS and coverslipped in an assembly 
DAPI-containing Vectashield® solution (Hard Set Mounting Medium®, Vector laboratory, 
Burlingame, CA, USA) when appropriate.  The slides and cultures were stored in the dark at 
4°C.  Omission of primary antibodies resulted in a complete loss of detectable signal.  
Moreover, some slides were stained with Hematoxylin/Eosin in order to observe the tumor 
mass. 
 
Image acquisition and data analysis 
Immunostained sections were imaged and examined using a laser-scanning confocal 
microscope equipped with a krypton/argon gas layer (Olympus® Fluoview 1000, Aartselaar, 
Belgium). We also used Zeiss Axiovert 10® microscope (Car Zeiss®, Zaventem, Belgium) 
coupled with Mercator® software (Explora Nova®, La Rochelle, France) for automatically cell 
counting within anatomical regions. Figures were composed using ImageJ® (public domain 
Java image processing program, author: Wayne Rasband, National Institute of Mental Health, 




Brain xenografts and tumor sphere experiments were repeated at least three times and 
representative results are illustrated.  Where applicable, chi-square test was used to compare 
tumorigenicity between groups.  Quantitative data were presented as means + SD and a P 
value of <0.05 was considered statistically significant. 
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 Results 
 
Validation of the intrastriatal xenograft of GBM cells as a model of cancer cell 
migration 
To test whether human glioblastoma (GBM) cells are attracted to neurogenic zones, human 
U87MG cells were injected into the right striatum of immunodeficient mice using a 
stereotactic frame.  This site is 1.2 mm distant from the ipsilateral subventricular zone (SVZ) 
but also 1.1 mm from the dentate gyrus in the hippocampus (Fig. 1a).  We first checked that 
the injection is not responsible of expelling cells into the SVZ by sacrificing animals 24 hours 
after the surgery.  We located human cells in the adult mouse brain using antibodies 
specifically directed against Human Mitochondria (Fig. 1b) or Nuclei.  The species-specificity 
of these antibodies was confirmed by the selective labeling of human astrocytes but not 
mouse astrocytes (data not shown) and by the injection of cells of the U87MG cell line 
previously stably transfected with a plasmid expressing a red fluorescent protein (Fig. 1d, 
DsRed). The small red tumor formed after two weeks was specifically labeled with the 
antibodies directed against Human Mitochondria (Fig. 1d, green) or Nuclei (data not shown).  
In contrast, the mouse brain was completely clear of any signal in these conditions. 
 
GBM cells invade the adult mouse subventricular zones and migrate to the olfactory 
bulb after their injection 
Four weeks after the injection in the right striatum, as mice developed tumor masses (TM), we 
identified U87MG cells in the right SVZ as well as in the left (contralateral) SVZ (Fig. 1f).  
These cells appeared to have migrated and reached these regions during the fourth week post-
injection, as they are not seen during the first three weeks post-implantation (Fig. 1e).  
Migrating human cells were observed in one the main fiber tract structure connecting the right 
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and left SVZ (i.e., the corpus callosum, Fig. 1f’), but did not follow the blood vessels (Fig. 1f, 
CD31-staining of endothelial cells). No cells could be observed in the right or left dentate 
gyrus (data not shown).  In the SVZ, U87MG cells were intermingled with normal NSC (Fig. 
2a).  Since adult NSC in the SVZ can divide asymmetrically and give rise to neuroblasts that 
differentiate while migrating towards the OB through the rostral migratory stream (RMS),24 
we looked for the presence of human cells both in the RMS and in the OB.  Human U87MG 
cells were indeed found migrating to the granular layer of OB (Fig. 2b).  In order to better 
analyze this migration, we performed sagittal sections of the left striatum, opposite to the 
tumor injection site, and demonstrated the presence of glioma cells in the more anterior part 
of the left SVZ, throughout the left RMS and into the glomerular layer of the left OB (Fig. 
2c). 
 GB138 cells were first established a GIC long term expanding culture (GB138 cells, see 
2.2 cell cultures) and conclusively demonstrated its tumorigenic properties following serial 
orthotopic transplantations in immunodeficient mice. We next investigate if GB138 cells 
invade the SVZ niches in a similar fashion as their U87MG counterpart. Tumors formed by 
GB138 cells were infiltrative, do not form tumor mass and some of these cells were found in 
the ipsilateral SVZ six weeks after the injection (supplementary data Table 1b).  Two weeks 
later, GB138 cells migrate across the corpus callosum until the controlateral neurogenic niche 
(supplementary data Table 1c).  Moreover, some GB138 cells migrate through the RMS to the 
OB of both hemispheres within the next two weeks (Fig. 3a and b).  Interestingly, we never 
observed GB138 cells in other anatomical structures such as the controlateral cortex or the 
dentate gyrus of the hippocampus, even 10 weeks after the implantation (Fig. 3a).  These 
results suggest a tropism of GB138 invading cells for the SVZ and from there, for the OB.  
 
U87MG and GB138 human GBM cells express stem cells markers in vivo   
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In order to better characterize the phenotype of tumor cells found in the neurogenic zones, we 
studied the expression of Sox2, Nestin and CD133.  Sox2 is a highly conserved HMG box 
transcription factor that plays an important role in the maintenance of NSC and is expressed in 
SVZ in the adult brain.25 Moreover, the inhibition of Sox2 in GIC leads these particular cells 
to stop their proliferation and to lose their tumorigenicity in immunodeficient mice.26 In our 
experiments, two weeks after stereotactic right striatal injection, Sox2-positive U87MG cells 
were present heterogeneously in the tumor mass (Fig. 4a).  This observation is not surprising 
as it was recently shown that Sox2 is widely expressed in GBM.27 However, 4 weeks after 
surgery, Sox2-expressing U87MG cells were mainly observed at the edge of the tumor mass 
facing the neurogenic niche, along and into the SVZ (Fig. 4b-c). Unlike U87MG cells, GB138 
cells form a more invasive tumor and are Sox2-positive wherever they are located in the 
brain, in the neurogenic zone, in the OB or during their migration through the corpus 
callosum and the RMS (Fig. 5a).  We next examined the expression of Nestin.  This 
intermediate filament-associated protein is expressed mostly in dividing cells during the early 
stages of development and the adult neurogenesis and now generally regarded as a classical 
marker for brain NSC.28 We demonstrated that Nestin is expressed by Sox2-positive U87MG 
invading cells (Fig. 4c) and by most of the GB138 cells (Fig. 5b).  Finally, we used an 
antibody directed against CD133, a cell surface glycoprotein expressed in GBM.29 We didn’t 
observe any staining of U87MG cells both in vivo (and in vitro, data not shown).  In contrast, 
GB138 cells largely expressed CD133 (Fig. 5c) and are labeled with an antibody directed 
against GFAP (Fig. 5d).   
 At the same time, we studied the expression of neuronal markers (NeuN, GABA and 
B-III-tubulin) in order to highlight the differentiation of U87MG cells migrating to the OB but 
didn’t observe any signals (data not shown).   Indeed, true neuroblasts generated from NSC in 
SVZ differentiate into neurons while integrating the OB.30 However, some U87MG cells 
located in SVZ expressed Doublecortin (Dcx), a microtubule associated-protein 
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(supplementary data Fig. 1).  Dcx plays a role in the neuroblasts migration to the OB both 
during development and in adulthood and is considered as an early marker of neuronal 
specification and differentiation.31 Interestingly, U87MG cells expressing Dcx are nestin-
negative as it is observed within host neuroblast. 
 To conclude, we were unable to distinguish a specific profile of stem cells markers for 
GB138 cells invading the SVZ from those located in the bulk of cells in the striatum as we did 
for U87MG cell line.  These results correlate with recent studies proving that self-renewing 
capacities of GIC seem to be not limited to a uniform population of cancer stem cells, but can 
be linked with cell lineages expressing a range of markers.32  
 
U87MG cells isolated from the TM, SVZ and the OB formed self-renewable spheres 
under specific in vitro conditions 
To further investigate the biological properties of GBM cells found in the neurogenic zones, 
we decided to carry out their ability to initiate self-renewable “spheres” when cultured in 
specific conditions.  Notably, GIC has to meet this criterion.  Due to the very slow growth rate 
of GB138 cells, we decided to focus on U87MG cells.  Thus, we isolated U87MG cells 
specifically from the tumor mass (TM), the ipsi- and contro- lateral SVZ and the OB of 
immunodeficient mice four weeks after their striatal injection (Fig. 6a).  Cells obtained from 
these mouse brain regions were cultivated in a specific cell culture medium used for NSC and 
GIC.  In these conditions, we could easily select U87MG cells that were able to form Nestin-
positive spheres (Fig. 6b).  Moreover, single cells obtained from the dissociation of these 
primary spheres have the ability to form secondary spheres that are also Nestin-positive (Fig. 
6b).  These experiments suggest the self-renewability of the U87MG cell populations derived 
from the four anatomical regions (TM, ipsi- or controlateral SVZ and OB).  
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Injection of distant invaders to new immunodeficient mice rapidly induced the 
formation of a tumor 
The operational definition of GIC includes the ability to initiate tumor in xenograft models.  
To evaluate the experimental tumorigenicity of the migrating GBM cells, we performed 
injection of 50.000 human U87MG cells harvested from the primary tumor mass, the 
ipsilateral SVZ, the controlateral SVZ and the OB into immunosuppressed mice.  Accordingly 
with former studies, mice grafted with these previously injected and then re-purified U87MG 
cells had to be sacrificed two weeks after the grafting procedure because they were dying.  
Hematoxylin/Eosin (H/E) coloration showed the formation of a very large tumor in the right 
hemisphere (Fig. 6c).  The large size of these secondary tumors observed two weeks after 
injection were never observed in the case of primary tumors four weeks after injection and 
prevents us to observe a new specific migration of human U87MG cells into neurogenic 
zones. It is now known that GIC responsible to experimental tumor represent a minor subset 
of the total cells within GBM, like in U87MG cell line.33 It is possible to estimate the amount 
of GIC using dilution assays through xenograft in immunodeficient mice brain.5 To do so, we 
then injected only 100 U87MG cells harvested from the primary tumor mass, the ipsilateral 
SVZ, the controlateral SVZ and the OB into the striatum of adult mice.  As injection of 100 
native U87MG cells never induce tumors, we observed the formation of three tumors out of 
twelve mice injected with 100 cells from the primary tumor mass, five tumors out of eleven 
mice injected with 100 cells from the controlateral SVZ, one tumor out of six mice injected 
with 100 cells from the ipsilateral SVZ and finally two tumors out of nine mice injected with 
100 cells from the OB (Fig. 6c).  Those tumors harbour the same infiltrative behaviour as the 
naïve U87MG cells. Chi-square test analysis between the four conditions was not significant 
showing the same enrichment in GIC in the different populations of U87MG cells.  In 
conclusion, we have demonstrated that a few GBM cells refugee in the neurogenic niches 
could initiate tumor. 
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 Discussion 
The concept of cancer-initiating cells34 has been extended to human glioblastoma multiforme 
(GBM) with the discovery in these tumors of multipotent cells capable of both self-renewal 
and malignant tumor formation.4 The concept was strengthened with the experimental 
demonstration that GBM formation in mice may arise from genomic instability in one or in 
several NSC (and not astrocytes).35, 36 Moreover, glial tumors originating from different brain 
regions are molecularly distinct and might arise from distinct populations of site-restricted 
progenitor cells.37, 38 Clinical practices also brought neurogenic niches and malignant glioma 
together.  A recent study have showed that patients whose bilateral SVZ received greater than 
the median SVZ dose had a significant improvement in progression-free survival.39 
 Interestingly, cancer-initiating cells tend to hide in specific niches, such as the 
perivascular space, that influence their metabolism and maybe, their intrinsic treatment 
resistance.40 This is reminiscent of that of normal stem cells, which must remain located in 
neurogenic zones to maintain their stem cells characteristics.41  We have thus addressed the 
question whether the known neurogenic zone, the SVZ and the dentatus gyrus, could attract 
cancer-initiating cells of GBM or GIC.   
To test this hypothesis, we performed stereotactic injections of U87MG cells in the 
striatum of immunodeficient mice.  U87MG cells contain a very small population of 
multipotent and self-renewable cancer stem cells.33  We observed that, three to four weeks 
post-injection, U87MG cells that expressed the stem cell markers Nestin and Sox2 in the 
tumor mass were found mainly in the edge of the tumor facing the SVZ.  Moreover, some of 
these Sox2/Nestin-positive U87MG cells migrated towards the ipsi- and contro-lateral SVZ of 
host mice, where all tumor cells expressed these markers.  Interestingly, some GBM cells 
located in the neurogenic zones also migrated to the OB but their potential of differentiation is 
limited to the expression of the immature neurons marker Dcx.  However, we never observed 
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U87MG cells into the dentatus gyrus of hippocampus, suggesting a specific tropism for SVZ 
from these Sox2/nestin-positive U87MG cells. 
An important limitation of the use of U87MG cell line is that this brain tumor model 
did not resume typical characteristics of human GBM.42, 43 Therefore, we also used GIC 
derived from a primary GBM cell culture as they mimic more closely the infiltrative behavior 
of human GBM.  When injected in immunodeficient mice brains GIC derived from an acutely 
resected woman GBM (GB138 cells) show the same tropism for the neurogenic niches (SVZ) 
and then for the OB, but not for dentatus gyrus.  However, by comparison with U87MG cells, 
all GB138 cells expressed classical stem cell markers wherever they are.  This point is 
consistent with data demonstrating that cancer-initiating cells could be either CD133 positive 
or CD133 negative.44 According to this observation, numerous new studies describe GIC 
purification methods based on marker-independent strategies.45, 46  
Indeed, when isolated and purified from the various invaded brain regions, U87MG 
cells maintained their capacity to form primary and secondary spheres expressing Nestin in 
vitro when (sub)cultured in stem cell conditions.  Moreover, they induced rapidly the 
formation of very large tumors when re-injected in the striatum of immunodeficient mice.  In 
fact, these tumors developed at least two times faster than the native tumors.  This increased 
growth rate of secondary transplants (regarded as an aggressive behavior of the tumor) is 
largely described and is correlated with the enrichment of the fraction of GIC that yields faster 
growing tumors than other tumor cells.47 Therefore, we performed limiting dilution in vivo 
assays to determine variations in the frequency of cancer-initiating cells within U87MG cell 
populations.  Interestingly, this approach allows us to highlight the GIC feature of GBM cells 
refugee in the SVZ and OB, like for those forming the tumor mass.  Thus, although the 
distinct phenotype of cells present in the four anatomical regions is not clear, their biological 
behavior do appear similar or overlapping.  Actually, GIC located in the neurogenic zones 
have competencies for self-renewal and experimental tumor initiation.  This position distant 
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from the tumor mass and their intrinsic characteristic of GIC may allow them to escape 
current treatments.48, 49 
 Taken together, our observations demonstrate that SVZ and OB can attract and harbor 
glioblastoma-initiating cells.  Consequently, it is tempting to speculate that neurogenic zones 
may constitute a reservoir for tumor recurrence.  Notwithstanding a possible ‘niche’ influence 
of neurogenic zones on the intrinsic treatment resistance of tumor cells, the potential clinical 
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Figure 1. Immunodeficient mice injected with human U87MG cell suspension (50.000 
cells/2µl) develop tumor mass and human GBM cells fill the largest part of the right striatum 
at 3 weeks post-injection and invade the ipsi- and contra-lateral subventricular zones (SVZ) 
after 4 weeks.  (a) Human cells are slowly inoculated in the right striatum (red point) 
following stereotactical coordinates. Human U87MG cells are recognised using an antibody 
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specifically directed against human mitochondria while mouse and human cell nuclei are 
visualized using a DAPI staining. (b) Mice are sacrificed 24H and (c) 1 week after the surgery 
and. (d) The injection of red U87MG cells (transfected with a DsRed plasmid, red) for 2 
weeks validated the anti-human mitochondria antibody (H. Mitochondria, green). (e) 3 weeks 
after the xenograft, U87MG cells (H. Mitochondria, red) diffuse slightly in the striatum and 
(e’) are not present in the SVZ. (f) Interestingly, 4 weeks post-injection, tumor cells are found 
at the ipsilateral SVZ. Moreover, some human cells migrate to the contralateral SVZ. (f’) This 
migration occurs mainly along the corpus callosum and doesn’t seem to be linked to blood 
vessels labelled with an antibody directed against CD31 (endothelial cells, green). Nuclei are 
counterstained with DAPI (blue, b-f).  Scale bar = 150µm for b and c, = 120µm for d, = 
130µm for e, = 44,5µm for e’, = 150µm for f and = 51µm for f’.  TM – tumor mass, SVZ – 
subventricular zone. 
 
Figure 2. Some U87MG cells present in the neurogenic zone (subventricular zone or SVZ) 
migrate to the olfactory bulb (OB). (a) U87MG cells are observed both in the tumor mass 
(TM, represented by the numerous red circles) and in the ipsilateral subventricular zone on 
coronal sections processed on mice previously injected with 50.000 U87MG cells for 4 weeks 
(green). (b) Some human cells are found in the ipsilateral olfactory bulb (green). (c) As 
U87MG cells also migrate to the left SVZ, sagittal sections are obtained in the contralateral 
hemisphere. The migration of GBM cells from the SVZ to the OB occurs by the rostral 
migratory stream (RMS).  Human U87MG cells (red) are present in the most anterior part of 
the left SVZ, in the left RMS characterised by an astrocytic barrier (GFAP positive cells, 
green) and in the glomerular layer of the left OB. (a-c) Nuclei are counterstained with DAPI 
(blue).  H.M. - Human mitochondria signal.  Scale bar = 40µm for a and b and = 50 µm for c. 
 
Figure 3. As U87MG cells, some GB138 cells invade the neurogenic niches when injected 
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into the right striatum of immunodeficient mice.  After 10 weeks, human cells labelled with 
an antibody directed against human nuclei are found in the ipsi- and contra- lateral SVZ. (a) 
Human cells quantification in the different anatomical regions with Mercator® software 
revealed that some GB138 cells specifically invaded the SVZ and are restricted to the left and 
right RMS in the anterior part of the mouse brain (b) as it is observed on coronal sections. The 
invasion of the contralateral hemisphere takes place through the corpus callosum (cc).  Left 
part of the table corresponds to the right hemisphere (dark gray) and the right part of the table 
represents the left hemisphere (clear gray).  GrO - granular cell layer of the olfactory bulb. 
GlA – glomerular layer of the accessory olfactory bulb.  E/OV – ependymal and 
subependymal layer/olfactory ventricule.  AO – anterior olfactory nucleus.  SVZ – 
subventricular zone.  CPu – caudate putamen (striatum).  DG - dentate gyrus. Bregma column 
in a is the distance of the section from the bregma. Scale bar = 160µm for b. 
 
Figure 4.  U87MG cells that have migrated into SVZ express Nestin and Sox2. (a) After 2 
weeks, U87MG cells injected into the immunodeficient mice brain form a small tumor mass 
(red). At this stage, only several GBM cells are Sox2-positive and their localisation is 
heterogeneous and scattered (red-green). (b) But after 4 weeks, U87MG cells have 
proliferated and a large tumor mass (TM) appears into the striatum.  Now, U87MG Sox2-
positive cells are observed in front of the right SVZ (red-green). (c’) In addition, these Sox2-
positive cells expressed also largely Nestin (green), another immature cell marker.  (c’’) 
These Nestin- Sox2-positive U87MG cells are also observed within the ipsilateral SVZ (red-
green-blue).  (a and b) Arrows show human cells expressing Sox2.  (c’ and c’’) Arrows show 
human cells positive for Sox2 and Nestin antibodies.  Nuclei are counterstained with DAPI.  
H.M. - Human Mitochondria signal (red).  Scale bar = 40µm for a and b and 60µm for c.  
 
Figure 5. Human GB138 cells expressed (a) Sox2, (b) CD133, (c) Nestin and (d) GFAP 
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(green) at 10 weeks after inoculation in immunodeficient mice brain. More precisely, GB138 
cells expressed these markers whichever the localization is: striatum (upper panels), 
subventricular zone (middle panels) and olfactory bulb (lower panels). H.Nuclei – Human 
Nuclei (red). Nuclei were marked with DAPI (blue). Scale bar = 65µm for a-d. 
   
Figure 6. U87MG cells isolated from the TM, the SVZ and the OB form self-renewable 
spheres in vitro and preserve their tumorigenicity in vivo.  (a) At 4 weeks post-injection, 
U87MG cells isolated from the tumor mass, the right SVZ, the left SVZ and the OB were 
seeded in the appropriate medium.  (b) Within 5-6 days, we observed spheres containing 
Nestin-positive cells in the different cultures (green).  New spheres containing Nestin-positive 
cells were obtained from single cell derived from primary spheres assessing their self-
renewability. (c) Secondary injections of 50.000 U87MG cells isolated from the primary TM, 
the ipsilateral and contralateral SVZ and the OB rapidly give rise to the formation of new 
tumors within two weeks (Hematoxylin/Eosin coloration).  Colorations show the presence of 
tumors.  In addition, several mice were injected with 100 U87MG cells isolated from the 
different regions and sacrificed 4 weeks later.  The development of a tumor mass was reported 
for each population (number of mice with a tumor / total number of animal).  Statistical 
analysis (chi-square test) was not significant. (b) Nuclei are counterstained with DAPI. Scale 
bar = 255µm for b and = 1,8mm for c. 
 
Supplementary data Table 1.  Quantification of the GB138 cells in the adult 
immunodeficient mice brain (a) 4 weeks, (b) 6 weeks, (c) 8 weeks and (d) 10 weeks after their 
injection.  Left parts of tables correspond to right hemispheres (dark gray) and right parts of 
tables represent left hemispheres (clear gray).  GrO - granular cell layer of the olfactory bulb. 
GlA – glomerular layer of the accessory olfactory bulb.  E/OV – ependymal and 
subependymal layer/olfactory ventricule.  AO – anterior olfactory nucleus.  SVZ – 
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subventricular zone.  CPu – caudate putamen (striatum).  cc – corpus callosum.  DG - dentate 
gyrus. Bregma column represents the distance of the section from the bregma. Data were 
obtained using Mercator® software. 
 
Supplementary data Figure 1.  Some U87MG cells locate in the SVZ express Doublecortin, 
a protein involved in the neuronal migration. (a) After 4 weeks, U87MG cells labeled with an 
antibody directed against specifically human mitochondria are present in SVZ (H.M. green) 
and some of them expressed Doublecortin (Dcx, red). Star marks one glioblastoma cells co-
expressing Dcx and Human Mitochondria (yellow). (b) Orthogonal projection confirms this 
result. Nuclei are counterstained with DAPI. Scale bar = 60µm for a. 
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Immunodeficient mice injected with human U87MG cell suspension (50.000 cells/2µl) develop tumor 
mass and human GBM cells fill the largest part of the right striatum at 3 weeks post-injection and 
invade the ipsi- and contra-lateral subventricular zones (SVZ) after 4 weeks.  (a) Human cells are 
slowly inoculated in the right striatum (red point) following stereotactical coordinates. Human 
U87MG cells are recognised using an antibody specifically directed against human mitochondria 
while mouse and human cell nuclei are visualized using a DAPI staining. (b) Mice are sacrificed 24H 
and (c) 1 week after the surgery and. (d) The injection of red U87MG cells (transfected with a 
DsRed plasmid, red) for 2 weeks validated the anti-human mitochondria antibody (H. Mitochondria, 
green). (e) 3 weeks after the xenograft, U87MG cells (H. Mitochondria, red) diffuse slightly in the 
striatum and (e’) are not present in the SVZ. (f) Interestingly, 4 weeks post-injection, tumor cells 
are found at the ipsilateral SVZ. Moreover, some human cells migrate to the contralateral SVZ. (f’) 
This migration occurs mainly along the corpus callosum and doesn’t seem to be linked to blood 
vessels labelled with an antibody directed against CD31 (endothelial cells, green). Nuclei are 
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counterstained with DAPI (blue, b-f).  Scale bar = 150µm for b and c, = 120µm for d, = 130µm for 
e, = 44,5µm for e’, = 150µm for f and = 51µm for f’.  TM – tumor mass, SVZ – subventricular zone. 
361x541mm (72 x 72 DPI)  
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Some U87MG cells present in the neurogenic zone (subventricular zone or SVZ) migrate to the 
olfactory bulb (OB). (a) U87MG cells are observed both in the tumor mass (TM, represented by the 
numerous red circles) and in the ipsilateral subventricular zone on coronal sections processed on 
mice previously injected with 50.000 U87MG cells for 4 weeks (green). (b) Some human cells are 
found in the ipsilateral olfactory bulb (green). (c) As U87MG cells also migrate to the left SVZ, 
sagittal sections are obtained in the contralateral hemisphere. The migration of GBM cells from the 
SVZ to the OB occurs by the rostral migratory stream (RMS).  Human U87MG cells (red) are present 
in the most anterior part of the left SVZ, in the left RMS characterised by an astrocytic barrier 
(GFAP positive cells, green) and in the glomerular layer of the left OB. (a-c) Nuclei are 
counterstained with DAPI (blue).  H.M. - Human mitochondria signal.  Scale bar = 40µm for a and b 
and = 50 µm for c.  
333x516mm (72 x 72 DPI)  
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As U87MG cells, some GB138 cells invade the neurogenic niches when injected into the right 
striatum of immunodeficient mice.  After 10 weeks, human cells labelled with an antibody directed 
against human nuclei are found in the ipsi- and contra- lateral SVZ. (a) Human cells quantification 
in the different anatomical regions with Mercator® software revealed that some GB138 cells 
specifically invaded the SVZ and are restricted to the left and right RMS in the anterior part of the 
mouse brain (b) as it is observed on coronal sections. The invasion of the contralateral hemisphere 
takes place through the corpus callosum (cc).  Left part of the table corresponds to the right 
hemisphere (dark gray) and the right part of the table represents the left hemisphere (clear gray). 
 GrO - granular cell layer of the olfactory bulb. GlA – glomerular layer of the accessory olfactory 
bulb.  E/OV – ependymal and subependymal layer/olfactory ventricule.  AO – anterior olfactory 
nucleus.  SVZ – subventricular zone.  CPu – caudate putamen (striatum).  DG - dentate gyrus. 
Bregma column in a is the distance of the section from the bregma. Scale bar = 160µm for b.  
361x370mm (72 x 72 DPI)  
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U87MG cells that have migrated into SVZ express Nestin and Sox2. (a) After 2 weeks, U87MG cells 
injected into the immunodeficient mice brain form a small tumor mass (red). At this stage, only 
several GBM cells are Sox2-positive and their localisation is heterogeneous and scattered (red-
green). (b) But after 4 weeks, U87MG cells have proliferated and a large tumor mass (TM) appears 
into the striatum.  Now, U87MG Sox2-positive cells are observed in front of the right SVZ (red-
green). (c’) In addition, these Sox2-positive cells expressed also largely Nestin (green), another 
immature cell marker.  (c’’) These Nestin- Sox2-positive U87MG cells are also observed within the 
ipsilateral SVZ (red-green-blue).  (a and b) Arrows show human cells expressing Sox2.  (c’ and c’’) 
Arrows show human cells positive for Sox2 and Nestin antibodies.  Nuclei are counterstained with 
DAPI.  H.M. - Human Mitochondria signal (red).  Scale bar = 40µm for a and b and 60µm for c.  
500x423mm (72 x 72 DPI)  
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Human GB138 cells expressed (a) Sox2, (b) CD133, (c) Nestin and (d) GFAP (green) at 10 weeks 
after inoculation in immunodeficient mice brain. More precisely, GB138 cells expressed these 
markers whichever the localization is: striatum (upper panels), subventricular zone (middle panels) 
and olfactory bulb (lower panels). H.Nuclei – Human Nuclei (red). Nuclei were marked with DAPI 
(blue). Scale bar = 65µm for a-d.  
361x270mm (72 x 72 DPI)  
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U87MG cells isolated from the TM, the SVZ and the OB form self-renewable spheres in vitro and 
preserve their tumorigenicity in vivo.  (a) At 4 weeks post-injection, U87MG cells isolated from the 
tumor mass, the right SVZ, the left SVZ and the OB were seeded in the appropriate medium.  (b) 
Within 5-6 days, we observed spheres containing Nestin-positive cells in the different cultures 
(green).  New spheres containing Nestin-positive cells were obtained from single cell derived from 
primary spheres assessing their self-renewability. (c) Secondary injections of 50.000 U87MG cells 
isolated from the primary TM, the ipsilateral and contralateral SVZ and the OB rapidly give rise to 
the formation of new tumors within two weeks (Hematoxylin/Eosin coloration).  Colorations show 
the presence of tumors.  In addition, several mice were injected with 100 U87MG cells isolated from 
the different regions and sacrificed 4 weeks later.  The development of a tumor mass was reported 
for each population (number of mice with a tumor / total number of animal).  Statistical analysis 
(chi-square test) was not significant. (b) Nuclei are counterstained with DAPI. Scale bar = 255µm 
for b and = 1,8mm for c.  
451x370mm (72 x 72 DPI)  
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